The largest database of trusted experimental protocols

Recombinant human serum albumin

Manufactured by Merck Group
Sourced in United States

Recombinant human serum albumin is a laboratory product that serves as a source of purified human albumin protein. Albumin is the most abundant plasma protein in the human body and plays a crucial role in maintaining osmotic pressure and transporting various substances. The recombinant version is produced through biotechnological processes, providing a reliable and consistent supply of this important biomolecule for various research and diagnostic applications.

Automatically generated - may contain errors

10 protocols using recombinant human serum albumin

1

Droplet-based Cellular Antibody Secretion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Aqueous phase I contained either the isolated cells (cellular measurements) or purified monoclonal antibodies (calibration experiments). For the list of calibration antibodies used, please refer to Supplementary Table 1. The isolated cells were centrifuged at 300 × g for 5 min, then the cell pellet was gently re-suspended in cell medium to achieve a concentration of 5–10 million cells/ml. In order to minimize antibody secretion before droplet formation, the cell suspension was prepared just before droplet formation; and kept on ice for short-term storage. Cell medium was composed of RPMI 1640 with no phenol red, supplemented with 0.1% Pluronic F-68, 25 mM HEPES pH 7.4, 10% KnockOut Serum Replacement (all ThermoFisher), and 0.5% recombinant human serum albumin (Sigma Aldrich, A0237).
+ Open protocol
+ Expand
2

Synthesis and Characterization of Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
All
chemicals used in the nanoparticle synthesis
were purchased from Merck and used as received unless otherwise indicated.
The exceptions were (1-cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino-carbenium
hexafluorophosphate (COMU) that was purchased from Carl Roth, 2-ethyl-2-oxazoline
that was dried over CaH2 before use, and methyl-p-toluenesulfonate that was distilled before use. (4-(2-Hydroxyethyl)-1-piperazineethanesulfonic
acid) (HEPES), NaCl, KCl, recombinant human serum albumin, hen egg
lysozyme, human transferrin, and human immunoglobulin G (IgG) from
serum were purchased from Sigma-Aldrich. Regenerated cellulose 0.22
μm syringe filters were purchased from Bruckner Analysentechnik.
+ Open protocol
+ Expand
3

Bulk Cell Sorting and Single-Cell Cloning

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bulk cell sorting and single‐cell deposition cloning was performed using a BD Influx cell sorter (BD Biosciences) based on a method described previously (Evans et al., 2015). For the bulk sort, 2 × 107 cells were treated with nnAA for 2 or 4 hr and harvested by centrifugation. The cells were washed and stained with AF488‐conjugated anti‐human IgG (Fc specific) using sorting buffer containing PBS, 0.5% recombinant human serum albumin (Sigma, St. Louis, MO), 5 mM ethylenediaminetetraacetic acid (Life Technologies) and 25 mM HEPES (Calbiochem, San Diego, CA). Based on high and low AF488‐fluorescence intensity gated fractions, 2.5 × 105 cells were deposited into 5‐ml collection tubes containing the culture medium. The sorted cells were centrifuged, resuspended in 2.5 ml fresh culture medium and plated into six‐well plates. For single‐cell cloning, 1 × 106 cells (nnAA‐treated and stained with AF488‐conjugated anti‐human IgG [Fc specific] antibody) were sorted from the AF488‐gated fraction by depositing one cell per well into individual wells of 384‐well plates containing conditioned medium. All plates were incubated at 37°C in a humidified atmosphere with 6% CO2 for outgrowth.
+ Open protocol
+ Expand
4

Preparation and Characterization of FLT3 Inhibitor Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
AGP purified from human or bovine plasma (Sigma) was resuspended in unsupplemented RPMI1640 (Gibco) at 10 mg/mL for working stocks. Recombinant human serum albumin (Sigma) was resuspended in RPMI1640 at 100 mg/mL. Lyophilized bovine plasma (Sigma) was reconstituted in sterile PBS (Gibco). TTT-3002 was a generous gift of TauTaTis, Inc. Lestaurtinib, midostaurin, sorafenib, and quizartinib were purchased from LC Laboratories. Each FLT3 TKI was dissolved at 10 mmol/L in 100% sterile-filtered dimethylsulfoxide (DMSO, Sigma). Mifepristone (Sigma) was dissolved at 100 mmol/L in 100% DMSO. Trihexyphenidyl hydrochloride (Selleckchem) was dissolved at 100 mmol/L in methanol. For cell-based assays, working stocks of 10 μmol/L were prepared for each drug in RPMI1640 supplemented with 0.1% DMSO and 0.2% BSA. For spectrophotometric studies, working stocks of 10 μmol/L were prepared using PBS without sera or albumin. ANS (Sigma) was dissolved in DMSO at 200 mmol/L and then diluted to 400 μmol/L with PBS (0.2% DMSO, final). Western blot analysis was performed using the FLT3 S-18 antibody (Santa Cruz Biotechnology) and for other proteins as indicated (Cell Signaling Technology).
+ Open protocol
+ Expand
5

Single-cell metabolic analysis protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were stained with either CellTrace™ Violet (Thermo Fisher, C34571), CellTrace™ Far Red (Thermo Fisher, C34564), or pHrodo™ Green AM (Thermo Fisher, P35373) at 2 × 106 cells per mL. CellTrace™ Violet (5 μM) and pHrodo™ Green AM (10 μM, addition of 1X PowerLoad™) stainings were performed in HBSS for 30 min on ice, CellTrace™ Far Red (1 μM) staining in HBSS for 10 min on ice. After incubation, the cells were washed with ice-cold MACS buffer. The cells were collected (400 g, 5 min, 4 °C) and re-suspended in ice-cold assay buffer (RPMI 1640 without phenol red, #11835063, 10% (v/v) KnockOut Serum Replacement, #10828010, 1X penicillin–streptomycin, #10378016, 25 mM MOPS pH 7.5, #J61843, 0.1% (v/v) Pluronic F-127, #11835030, all Thermo Fisher, and 0.5% (w/v) recombinant human serum albumin, Sigma Aldrich, A9731) to achieve a λ (mean number of cells per droplet) of 0.25–0.50.
Lactate standards (Lactate Assay Kit, Sigma-Aldrich, MAK064) with concentrations from 2 to 200,000 amol/nL were prepared. IgG (Kerafast, EFD006) and IgM isotype controls (Biolegend, 401,601) of 100 nM were prepared, with eight serial dilutions by a factor 2.
+ Open protocol
+ Expand
6

Baculovirus Infection Induction and Cryopreservation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant baculovirus was generated by transfection of Sf9 cells using the TransIT-Insect transfection reagent (Mirus Bio) according to the manufacturer’s instructions. Seventy-two hours post-transfection, the baculovirus infectious titer was determined using the BacPAK Baculovirus Rapid Titer Kit (Takara Bio). BIIC production was performed as described in Wasilko and Lee.23 Briefly, naive Sf9 cells were infected with baculovirus using an MOI of 0.1 and, after 72 h, assayed for greater than 2-μm increase in cell diameter using a Countess Cell Counter (ThermoFisher). BIIC cultures that showed a greater than 2-μm increase in cell diameter were harvested and frozen in medium containing fresh Sf-900 III SFM media (ThermoFisher), 10% DMSO (Sigma), and 10 mg/mL recombinant human serum albumin (Sigma) using a Mr. Frosty freezing container (ThermoFisher).
+ Open protocol
+ Expand
7

Characterization of FLT3 Inhibitor Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
AGP purified from human or bovine plasma (Sigma) was resuspended in unsupplemented RPMI 1640 (Gibco) at 10 mg/mL for working stocks. Recombinant human serum albumin (Sigma) was resuspended in RPMI 1640 at 100 mg/mL. Lyophilized bovine plasma (Sigma) was reconstituted in sterile PBS (Gibco). TTT-3002 was a generous gift of TauTaTis, Inc. (San Diego, CA). Lestaurtinib, midostaurin, sorafenib and quizartinib were purchased from LC Laboratories. Each FLT3 TKI was dissolved at 10 mM in 100% sterile-filtered dimethylsulfoxide (DMSO, Sigma). Mifepristone (Sigma) was dissolved at 100 mM in 100% DMSO. Trihexyphenidyl hydrochloride (Selleckchem) was dissolved at 100 mM in methanol. For cell-based assays, working stocks of 10 μM were prepared for each drug in RPMI 1640 supplemented with 0.1% DMSO and 0.2% bovine serum albumin. For spectrophotometric studies, working stocks of 10 μM were prepared using PBS without sera or albumin. 8-anilinonaphthalene1-sulfonic acid (ANS, Sigma) was dissolved in DMSO at 200 mM, and then diluted to 400 μM with PBS (0.2% DMSO, final). Western analysis was performed using the FLT3 S-18 antibody (Santa Cruz), and for other proteins as indicated (Cell Signaling Technology).
+ Open protocol
+ Expand
8

Endoglin-GFP Influence on BMP9/10 Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
C2C12-BRE cells [51 (link)] were seeded at 30,000 cells/well in 96-well plates and grown for 3 days in DMEM containing 10% heat-inactivated FBS and antibiotic/antimycotic (Thermo Fisher Scientific, Waltham, MA, USA). Cells were then washed once with DMEM containing 0.1% FBS and antibiotic/antimycotic; after aspiration of the washed, they were incubated in fresh 0.1% FBS overnight. The endoglin–GFP protein was expressed using the EGFP–N1–EndoglinCDS1 plasmid and purified with Strep-Tactin®XT (GenScript Biotech, Leiden, The Netherlands). As the provided dilution of the protein stock (30 µg/mL) was limiting, media for the incubations were prepared using 10X M199 (Sigma-Aldrich, St. Louis, MO, USA). Dilutions of BMP9 or BMP10 (both from R&D Systems, Minneapolis, MN, USA) were incubated in the absence or presence of endoglin–GFP in M199 containing 1.5 mg/mL sodium bicarbonate, 4 mM L-glutamine, 25 mM Hepes, and 0.5% recombinant human serum albumin (Sigma-Aldrich, St. Louis, MO, USA). ALK1-Fc (R&D Systems, Minneapolis, MN, USA) was included as a positive control.
+ Open protocol
+ Expand
9

VEGF-Mediated Tumor Angiogenesis Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human VEGF165 (239-VE-010) was obtained from R&D (Minneapolis, MN, USA). Recombinant human serum albumin (HSA) was purchased from Sigma-Aldrich (St Louis, MO, USA). Mouse serum albumin (MSA) was from Equitech-Bio (Kerrville, TX, USA). Cyclophosphamide (CTX) was from Jiangsu Hengrui Medicine (Lianyungang, China). Avastin was from Roche (Basel, Switzerland). The Growth Factor Reduced Matrigel (356230) was obtained from BD Biosciences (Franklin Lakes, NJ, USA). Anti-VEGFR2 (#2479), anti-phospho-VEGFR2 (Y1175) (#2478), anti-PI3K (#4292), anti-Phospho-PI3 Kinase p85 (Y458)/p55 (Y199) (#4228), anti-AKT (#4691), anti-phospho-AKT (S473) (#4060) antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA). Anti-VEGFR1 mAb (TA303515) was from OriGene (Rockville, MD, USA). Anti-phospho-VEGFR1 (Y1213) rabbit antibody (AF4170) was purchased from R&D. Anti-albumin (#46293) was purchased from Santa Cruz (Santa Cruz, CA, USA). Anti-F56/F56-CM monoclonal antibody 9G10 and 9G10-HRP were generated in our lab 10 (link).
+ Open protocol
+ Expand
10

Production of Purified rshCD5 Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Production of purified rshCD5 protein (PBS with 10% glycerol, pH 7.4) was carried out as previously reported [38 (link)] but using stable transfected SURE CHO-M Cell line™ clones from the Selexis SUREtechnology Platform™ (Geneva, Switzerland) and subjecting their serum-free supernatants to size-exclusion chromatography protocols developed at PX´Therapeutics (Grenoble, France). Recombinant Human Serum Albumin (HSA; in PBS with 10% glycerol, pH 7.4) was from Sigma-Aldrich.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!